Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124633124 | 12463312 | 4 | F | 20160624 | 20160614 | 20160708 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-118423 | RANBAXY | 78.00 | YR | F | Y | 0.00000 | 20160708 | OT | GB | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124633124 | 12463312 | 1 | PS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | U | 90494 | |||||||||
| 124633124 | 12463312 | 2 | I | PACLITAXEL. | PACLITAXEL | 1 | Unknown | WEEKLY, 6 COURSES, THE DOSE WAS 60.0MG PER WEEK | U | 0 | 40 | MG/M**2 | |||||||
| 124633124 | 12463312 | 3 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | WEEKLY, 6 COURSES | U | 0 | 40 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124633124 | 12463312 | 1 | Myocardial infarction |
| 124633124 | 12463312 | 2 | Lung squamous cell carcinoma stage II |
| 124633124 | 12463312 | 3 | Lung squamous cell carcinoma stage II |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124633124 | 12463312 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124633124 | 12463312 | Drug interaction | |
| 124633124 | 12463312 | Leukopenia | |
| 124633124 | 12463312 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |